Center for Neurosciences
2450 E. River Road
Tucson, Arizona 85718
520-320-2147 http://www.neurotucson.com mpazzi@neurotucson.com

Use our guide to learn which trials are right for you!

THE CENTER FOR NEUROSCIENCES (CNS) is Southern Arizona's largest and longest-standing neuroscience medical practice whose mission is to deliver the highest standard of care. CNS has a dedicated Clinical Research Program with seven Principal Investigators and a full-time research nurse. The CNS investigators collectively have vast experience conducting numerous phase II -IV clinical trials in a broad range of neurologic diseases affecting adults and children.

The CNS Research Program was initiated in January 2009, however CNS Investigators and Staff have many years experience in conducting clinical trials previously at various facilities. They have worked with most major pharmaceutical companies and contract research organizations. Therapeutic areas that are currently the focus of CNS' Clinical Research Program include brain tumors, epilepsy (Adult and Peds), headache/migraine (Adult and Peds), multiple sclerosis, pain and movement disorders.

Epilepsy: David Teeple, MD - Board-certified Neurologist; Fellowship-trained in Epilepsy, Barrow Neurological Institute, Phoenix, AZ, has been a Principal Investigator on numerous phase II-III epilepsy clinical trials.

Neuro-Oncology: Michael Badruddoja, MD - Board-certified Neurologist; Fellowship-trained in Neuro-Oncology, Duke University Medical Center, RTOG Member

General Neurology: Horace Noland, MD - Board-certified Neurologist; has been PI on over 30 neurology clinical trials

Francisco Valdivia, MD - Board-certified Neurologist;has been Sub-investigator on over 15 neurology clinical trials, special interest in Multiple Sclerosis.

Pediatric Neurology:Dinesh Talwar, MD - Board-certified in Child Neurologist and Clinical Neurophysiologist; Fellowship-trained in EEG and Neurophysiology, University of Minnesota; special interest in childhood epilepsy and migraine
Monica Chacon, MD - Board-certified Child Neurologist; Fellowship-trained in Clinical Neurophysiology, University of Texas Health Sciences Center; special interest in childhood epilepsy

Robert Foote, MD- Board certified Neurologist, special interest in movement disorders and Parkinson's disease has been a Principal Investigator on several neurology clinical trials

Marjorie Pazzi, RN, BSN is the Site Director and Senior Research Nurse. She has been coordinating clinical trials for over 7 years and has 20 years experience in neuroscience nursing. She is a Certified Clinical Research Professional.

Kelly Wallen is the Research Assistant. She has a BS in physiology, and is currently enrolled in graduate school. She is a dedicated recruitment specialist for the Clinical Research Program and assists with regulatory file maintenance.


With over 200 patient visits per day, the Center for Neurosciences has a very extensive patient base from which to draw. CNS not only serves the metropolitan Tucson area, but also due to several outreach clinics serves 5 surrounding counties reaching about 1.5 million people in Southern Arizona. This region has a very culturally and ethnically diverse patient population, with 60% Caucasian, 30% Hispanic, 3% African American, 3% Native American, and 3% Asian. Three of our principal investigators are fluent Spanish speakers.


Neurology
Oncology
Pediatrics/Neonatology

In 2008, CNS opened a 30,000-square-foot, all digital, outpatient facility which brings the most advanced level of neurological care available to patients. CNS neurologists have vast experience in neurophysiology and the skilled neurophysiology technicians perform numerous electroneurodiagnostic tests daily. CNS has an on-site MRI, multiple exam rooms, a laboratory with centrifuge and a -20 freezer, secure study drug storage, an ECG machine and a monitor room with high-speed internet access. CNS also has a dedicated Interventional Pain Management Program.


Marjorie Pazzi, RN, BSN, CCRP
Site Director
Center for Neurosciences
2450 E. River Road
Tucson, AZ 85718
USA
520-320-2147
520-320-2149 (fax)
mpazzi@neurotucson.com
www.neurotucson.com


We've found
12 trials
at this facility
Alzheimer Disease Clinical Trial
Efficacy and Safety Study of Gantenerumab in Participants With Early Alzheimer's Disease (AD)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Tucson, AZ
Click here to add this to my saved trials
Neurology Clinical Trial
A 12-Month Study To Evaluate The Safety And Tolerability Of Pregabalin As Add-On Therapy In Pediatric Subjects 1 Month To 16 Years Of Age With Partial Onset Seizures And Pediatric And Adult Subjects 5 To 65 Years Of Age With Primary Generalized Tonic-Clonic Seizures
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Tucson, AZ
Click here to add this to my saved trials
Glioblastoma Multiforme Clinical Trial
A Feasibility Study of the Nativis Voyager® System in Patients With Recurrent Glioblastoma Multiforme (GBM)
Status: Enrolling
Updated: 12/31/1969
mi
from
Tucson, AZ
Click here to add this to my saved trials
Epilepsy Clinical Trial
A Study to Investigate the Safety of the Drugs Topiramate and Levetiracetam in Treating Children Recently Diagnosed With Epilepsy
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Tucson, AZ
Click here to add this to my saved trials
Multiple Sclerosis, Relapsing-Remitting Clinical Trial
Study to Evaluate the Effectiveness and Safety of Ocrelizumab in Participants With Early Stage Relapsing Remitting Multiple Sclerosis (RRMS)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Tucson, AZ
Click here to add this to my saved trials
Glioblastoma Clinical Trial
A Study of DSP-7888 Dosing Emulsion in Combination With Bevacizumab in Patients With Recurrent or Progressive Glioblastoma Following Initial Therapy
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Tucson, AZ
Click here to add this to my saved trials
Lennox Gastaut Syndrome Clinical Trial
A Study to Investigate the Efficacy and Safety of ZX008 (Fenfluramine Hydrochloride) as an Adjunctive Therapy in Children and Adults With Lennox-Gastaut Syndrome
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Tucson, AZ
Click here to add this to my saved trials
Herniated Lumbar Disk Clinical Trial
Confirmatory Clinical Study of Oxiplex
Status: Enrolling
Updated: 12/31/1969
mi
from
Tucson, AZ
Click here to add this to my saved trials
Neurology, Psychiatry / Psychology Clinical Trial
A Study of Aducanumab in Participants With Mild Cognitive Impairment Due to Alzheimer's Disease or With Mild Alzheimer's Disease Dementia to Evaluate the Safety of Continued Dosing in Participants With Asymptomatic Amyloid-Related Imaging Abnormalities
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Tucson, AZ
Click here to add this to my saved trials
Brain and Central Nervous System Tumors Clinical Trial
A Study Assessing BGB-290 With Radiation and/or Temozolomide (TMZ) in Subjects With Newly Diagnosed or Recurrent Glioblastoma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
mi
from
Tucson, AZ
Click here to add this to my saved trials
Symptomatic Neurogenic Orthostatic Hypotension Clinical Trial
Sustained Effect of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Status: Enrolling, Phase IV
Updated: 9/14/2017
mi
from
Tucson, AZ
Click here to add this to my saved trials
Alzheimer Disease (AD) Clinical Trial
A Study of LY3303560 in Participants With Early Symptomatic Alzheimer's Disease
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Tucson, AZ
Click here to add this to my saved trials